查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496751

生物製药辅料市场：按产品、特性和应用分类 - 全球预测 2024-2030

Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年生物药辅料市场规模为22.9亿美元，2024年将达25.3亿美元，2030年将达到47亿美元，复合年增长率为10.75%。

生物製药赋形剂是除治疗分子之外的物质，包含在生物製药配方中，有助于药物的製造、稳定性、可用性和递送。生物製药辅料在药物製剂中起着至关重要的作用。其用途广泛，包括粘合剂、填充剂、稀释剂、崩坏和稳定剂。对先进和功能性生物製药配方的需求不断增长以及对聚合物开发的需求不断增长正在推动生物製药辅料的采用。此外，药物开发投资的增加正在推动生物製药辅料的使用。然而，生物製药製剂和原料药之间的相容性问题仍然是一项重大挑战。此外，生技药品和生物相似药的持续发展增加了对相容赋形剂的需求。缓释性製剂的技术进步和替代给药途径的探索为市场拓展提供了巨大的潜力。

主要市场统计
基准年[2023] 22.9亿美元
预测年份 [2024] 25.3亿美元
预测年份 [2030] 47亿美元
复合年增长率（%） 10.75%

区域洞察

在美洲，美国凭藉其强大的製药产业、大量的研发投入以及稳定的FDA核准数量，在生物製药辅料市场占据主导地位。加拿大正在为该地区的需求做出贡献，两国对能够增强药物输送和稳定性的新型多功能辅料表现出浓厚的兴趣。欧盟 (EU) 国家拥有完善的製药业和严格的监管标准。消费者的需求是由生物相似药和生技药品的生产所驱动的，这需要高品质的原料。欧盟对研究和创新项目的持续投资表明了其对辅料开发的持续承诺，包括旨在提高生物製药性能和安全性的潜在专利申请。在亚太地区，人们非常重视新型辅料的创新和开发，政府大力推动製药业的升级。在印度这个学名药生产中心，对辅料的需求与成本效率和国际标准的合规性一致。在整个亚太地区，多样化的客户需求正在推动对特定辅料的需求，并有望推动市场成长。

FPNV定位矩阵

FPNV定位矩阵对于评估供应商在生物製药辅料市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对生物製药辅料市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在生物製药辅料市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对先进功能性生物製药配方的需求不断增长
      • 对聚合物开发的需求不断增加
      • 增加生物相似药的开发
      • 对荷尔蒙和基因治疗的需求增加
      • 全球疫苗大规模生产
    • 抑制因素
      • 生物製药辅料价格高
    • 机会
      • 生物製药製造外包新趋势
      • 功能性添加剂需求大幅增加
      • 重组DNA技术的发展
    • 任务
      • 生物製药辅料製造的复杂性与污染问题
      • 生物製药耗时的临床试验
  • 市场区隔分析
    • 产品：碳水化合物是药物製剂中用来确保製剂稳定性和患者依从性的主要赋形剂。
    • 功能：提高防腐剂利用率并提高生物製药的稳定性
    • 应用：生物製药辅料在先进的药物控制释放输送系统中的重要性日益增加
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章生物製药辅料市场：副产品

  • 碳水化合物
  • 多元醇
  • 增溶剂和界面活性剂/乳化剂
  • 特殊添加物

第七章生物製药辅料市场：依功能

  • 活页夹
  • 涂层
  • 崩坏
  • 润滑剂和润滑剂
  • 药物填充剂
  • 防腐剂

第八章生物製药辅料市场：依应用分类

  • 先进的输送系统
  • 口服
  • 胃肠外的
  • 话题

第九章美洲生物製药辅料市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物药辅料市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲生物药辅料市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Rocket推出三类营养食品保湿成分
    • Croda Pharma 开始兴建积层製造厂

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEFAD78

[189 Pages Report] The Biopharmaceutical Excipients Market size was estimated at USD 2.29 billion in 2023 and expected to reach USD 2.53 billion in 2024, at a CAGR 10.75% to reach USD 4.70 billion by 2030.

Biopharmaceutical excipients are substances other than therapeutic molecules that are included in a biopharmaceutical formulation to aid in the production, stability, usability, and delivery of the drug. Biopharmaceutical excipients play a pivotal role in drug formulation. Their applications span diverse categories, such as binders, fillers, diluents, disintegrants, and stabilizers. Rising demand for advanced and functional biopharmaceutical drug formulations and increasing need for large-molecule development are driving the adoption of biopharmaceutical excipients. In addition, rising investment in drug development is boosting the utilization of biopharmaceutical excipients. However, the compatibility issues of biopharmaceutical formulations with active pharmaceutical ingredients pose considerable challenges. Furthermore, the continuous development of biologics and biosimilars leads to an increased need for compatible excipients. Technological advancements in extended-release formulations and the exploration of alternative routes of administration provide significant potential for market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.29 billion
Estimated Year [2024] USD 2.53 billion
Forecast Year [2030] USD 4.70 billion
CAGR (%) 10.75%

Regional Insights

In the Americas, the United States stands as a dominant player within the biopharmaceutical excipients market due to a robust pharmaceutical industry, significant investment in R&D, and a steady number of FDA approvals. Canada contributes to regional demand, and both countries exhibit a high interest in novel, multifunctional excipients that enhance drug delivery and stability. European Union (EU) countries possess a well-established pharmaceutical sector with stringent regulatory standards. Consumer need is driven by the production of biosimilars and biologics that demand high-quality ingredients. Ongoing investments by the European Union in research and innovation programs indicate a continued commitment to excipient development, including potential patent applications that aim at improving the performance and safety of biopharmaceuticals. In the APAC region, the focus is on the innovation and development of new excipients and a strong government push for upgrading the pharmaceutical industry. In India, a hub for generic drug production, the excipient demand aligns with cost efficiency and compliance with international standards. Across the Asia Pacific, diverse customer needs steer the demand for specific excipients, which are expected to fuel market growth.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biopharmaceutical Excipients Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
      • Increasing Need for Large-Molecule Development
      • Increasing Development of Biosimilars
      • Increasing Demand for Hormone and Gene Therapy
      • Bulk Vaccine Production Worldwide
    • Market Restraints
      • High Price of Biopharmaceutical Excipients
    • Market Opportunities
      • Emerging Trends of Outsourcing for the Production of Biologics
      • Substantial Rise in Need of Functional Excipients
      • Developments in Recombinant DNA Technologies
    • Market Challenges
      • Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
      • Time Consuming Biopharmaceutical Clinical Trials
  • Market Segmentation Analysis
    • Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
    • Function: Increasing utilization of preservatives in biologic formulation for improved stability
    • Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopharmaceutical Excipients Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopharmaceutical Excipients Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Roquette launches three moisture-protecting ingredients for nutraceuticals

Roquette has expanded its portfolio of biopharmaceutical excipients with the introduction of three new grades specifically tailored to enhance the stability of moisture-sensitive active pharmaceutical and nutraceutical ingredients. The newly unveiled grades are the partially pregelatinized starch Lycatab CT-LM and two microcrystalline cellulose variants, Microcel 103 SD and Microcel 113 SD, which provide an unparalleled combination of stabilizing properties and moisture protection. [Published On: 2023-10-26]

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Croda Pharma has initiated the construction of an advanced manufacturing facility in Lamar, Pennsylvania, focused on producing advanced biopharmaceutical excipients crucial for cutting-edge drug delivery systems. With a footprint of 23,680 square feet, this facility is poised to significantly bolster the production of ingredients vital for mRNA vaccines, gene therapies, and innovative cancer treatments, fulfilling an emerging demand in therapeutic modalities. [Published On: 2023-06-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopharmaceutical Excipients Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Ashland Global Holdings Inc., BASF SE, Clariant International Ltd., Colorcon, Inc., Croda International PLC, DFE Pharma GmbH & Co KG, Eastman Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Sohne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Roquette Freres S.A., Sigachi Industries Limited, Spectrum Laboratory Products, Inc., SPI Pharma, Inc., The Dow Chemical Company, The Lubrizol Corporation, VWR International, LLC by Avantor, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Carbohydrates
      • Dextrose
      • Starch
      • Sucrose
    • Polyols
      • Mannitol
      • Sorbitol
    • Solubilizers & Surfactants/Emulsifiers
      • Esters
      • Triglycerides
    • Specialty Excipients
  • Function
    • Binders
    • Coatings
    • Disintegrants
    • Lubricants & glidants
    • Pharmaceutical Fillers
    • Preservatives
  • Application
    • Advanced Delivery System
    • Oral
    • Parenteral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
      • 5.1.1.2. Increasing Need for Large-Molecule Development
      • 5.1.1.3. Increasing Development of Biosimilars
      • 5.1.1.4. Increasing Demand for Hormone and Gene Therapy
      • 5.1.1.5. Bulk Vaccine Production Worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High Price of Biopharmaceutical Excipients
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Trends of Outsourcing for the Production of Biologics
      • 5.1.3.2. Substantial Rise in Need of Functional Excipients
      • 5.1.3.3. Developments in Recombinant DNA Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
      • 5.1.4.2. Time Consuming Biopharmaceutical Clinical Trials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
    • 5.2.2. Function: Increasing utilization of preservatives in biologic formulation for improved stability
    • 5.2.3. Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Biopharmaceutical Excipients Market, by Product

  • 6.1. Introduction
  • 6.2. Carbohydrates
  • 6.3. Polyols
  • 6.4. Solubilizers & Surfactants/Emulsifiers
  • 6.5. Specialty Excipients

7. Biopharmaceutical Excipients Market, by Function

  • 7.1. Introduction
  • 7.2. Binders
  • 7.3. Coatings
  • 7.4. Disintegrants
  • 7.5. Lubricants & glidants
  • 7.6. Pharmaceutical Fillers
  • 7.7. Preservatives

8. Biopharmaceutical Excipients Market, by Application

  • 8.1. Introduction
  • 8.2. Advanced Delivery System
  • 8.3. Oral
  • 8.4. Parenteral
  • 8.5. Topical

9. Americas Biopharmaceutical Excipients Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceutical Excipients Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Excipients Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Roquette launches three moisture-protecting ingredients for nutraceuticals
    • 12.3.2. Croda Pharma Breaks Ground on Excipients Manufacturing Facility

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK BIOPHARMACEUTICAL E